newsfilter
← Latest News
PR Newswire·

AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery

AbbVie (NYSE: ABBV) and Iambic, a clinical-stage life sciences and technology company developing novel medicines through its AI-driven discovery and...